PRFX
Painreform Ltd
NASDAQ: PRFX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.88
-7.84% today
Updated 2026-04-29
Market cap
$1.72M
P/E ratio
—
P/S ratio
101.35x
EPS (TTM)
$-7.47
Dividend yield
—
52W range
$2 – $12
Volume
0.6M
Painreform Ltd (PRFX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-16,200.00%
ROE
-90.40%
ROA
-38.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | $-2.09M | — | — | — |
| 2018 | $0.00 | $-828000.00 | — | — | — |
| 2019 | $0.00 | $-1.82M | — | — | — |
| 2020 | $0.00 | $-4.05M | — | — | — |
| 2021 | $0.00 | $-7.25M | — | — | — |
| 2022 | $86000.00 | $-8.79M | 82.56% | -10,312.79% | -10,223.26% |
| 2023 | $0.00 | $-9.34M | — | — | — |
| 2024 | $0.00 | $-14.59M | — | — | — |
| 2025 | $17000.00 | $-4.84M | -4,864.71% | -29,335.29% | -28,458.82% |